Catalyst Wire Dossier Catalyst Wire Dossier

Zyrtec 5.0 mg Chewable Tablet

cetirizine · Allergan
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Zyrtec 5.0 mg Chewable Tablet, covering 2010-07-05 to 2010-07-30. Get the full timeline:

Most recent: Clinical Trial Update: Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed) [Phase 4]

See pricing